Loading insider details...
Beta
Latest Form 4 (Sep 28, 2026): Purchase of 12,500 DMRA shares, $252.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 28, 2026 | Damora Therapeutics, Inc. (DMRA) | Purchase | 12,500 | $252.9K |
| Jun 22, 2026 | Zura Bio Ltd (ZURA) | Grant/Award | 51,000 | n/a |
| Jun 15, 2026 | Sagimet Biosciences Inc. (SGMT) | Grant/Award | 39,567 | n/a |
| Apr 1, 2026 | Damora Therapeutics, Inc. (DMRA) | Grant/Award | 500,000 | n/a |
| Feb 6, 2026 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 24,000 | n/a |
| Jan 27, 2026 | Arcus Biosciences, Inc. (RCUS) | Grant/Award | 31,000 | n/a |
| Dec 18, 2025 | Arcus Biosciences, Inc. (RCUS) | Sale | 11,225 | $245.7K |
| Nov 12, 2025 | Arcus Biosciences, Inc. (RCUS) | Exercise/Conversion | 50,291 | $61.7K |
| Oct 8, 2025 | Arcus Biosciences, Inc. (RCUS) | Exercise/Conversion | 12,500 | $15.3K |
| Jun 10, 2025 | Sagimet Biosciences Inc. (SGMT) | Grant/Award | 27,268 | n/a |